Carrot, formerly known as Virtual Field, announced an agreement to acquire GreenMan Vision, Inc., the company behind InSightVR. The acquisition adds intraocular lens, or IOL, simulation for cataract surgery to Carrot's VR testing and diagnostic platform. The move expands Carrot from vision diagnostics into vision simulation and unites two technologies used across more than 2,500 clinics and over 6 million eye exams.
A Platform Built on Visual Field Testing
Since 2018, Carrot has become the most widely used VR visual testing platform in eye care. Its technology is deployed in independent practices and enterprise networks, where it supports faster, more comfortable exams. AI and machine learning derived analysis and automation also help technicians and doctors save time on every exam while improving practice profitability.
Why Vision Simulation Matters
Cataract surgery is one of the most commonly performed surgeries in the United States and centers on a lifelong lens choice. Patients typically weigh tradeoffs involving glasses dependence, glare, and halos through conversations and brochures rather than direct experience. InSightVR was created to close that gap by using each patient's own biometry to simulate everyday scenes.
Clinical Evidence Supporting Patient Decisions
In a 2026 retrospective study of 609 patients published in Patient Preference and Adherence, 57.1% of InSightVR patients chose an advanced-technology lens compared with 28.4% using standard counseling. After surgery, 90% of surveyed patients who selected those lenses said their vision was similar to the simulation. The company stated that seeing changes the decision for many cataract patients.
Leadership Perspectives
Jeremy Barlow, CEO of Carrot, said patients have long dreaded visual field tests and that his company asked whether there was a better approach. He noted that GreenMan's founders asked why patients should choose how they will see for life without experiencing it first. Soon, Barlow said, both answers will live on the Carrot Platform.
GreenMan CEO Matt Larson said customers will retain the same team and service model. What will change, he added, is scale, because Carrot can bring InSightVR to more surgeons and patients than GreenMan could reach alone. Carrot already serves the ophthalmology practices where cataract surgery happens and the optometry practices that refer patients to them.
Drs. Greenwood and Baartman built InSightVR for their own patients and held it to a standard that it could never overpromise an outcome. Dr. Greenwood said the tool was created to close a gap in patient education. Dr. Baartman added that when patients can see the tradeoffs for themselves, the decision becomes theirs.
Integration, Support, and AAO 2026
Carrot will keep the same InSightVR team along with the hands-on training and support customers already rely on. The acquisition gives InSightVR access to Carrot's scale across ophthalmology and optometry practices. Carrot will showcase the integrated platform and IOL simulation at the American Academy of Ophthalmology 2026 Annual Meeting in New Orleans from October 10 to 12 at Booth #2409.
GreenMan InSightVR demonstrations will also be available separately at booth #4142 during the same meeting. The Carrot booth will host daily gatherings, including New Orleans bites and networking on Saturday, a Creole Creamery ice cream bar on Sunday, and beignets with café au lait on Monday. Attendees can schedule a demonstration of the combined platform and IOL simulation through the company's website.
Company Backgrounds
Carrot was founded in 2018 by an ophthalmologist and two engineers and invented virtual visual field testing. GreenMan Vision was founded by cataract surgeons Michael Greenwood, MD, and Brandon Baartman, MD, to help patients make informed lens decisions. Together, the companies aim to bring testing, diagnostics, and simulation onto one platform.
Carrot's planned acquisition of GreenMan InSightVR signals a broader shift toward patient-centered decision-making in eye care. By combining visual field testing with immersive IOL simulation, the company aims to support clinicians from first diagnostic exam to final lens choice. The announcement positions Carrot to play a larger role in one of the highest-value decisions in ophthalmology.